Jasper Therapeutics (JSPR) Net Income towards Common Stockholders (2020 - 2025)
Jasper Therapeutics' Net Income towards Common Stockholders came in at -$9.1 million for Q4 2025, compared with -$24.35 million a year earlier.
Powered by 
Analysis
Jasper Therapeutics (JSPR) Net Income towards Common Stockholders (2020 - 2025) Analysis & Trends
For FY2025, Jasper Therapeutics' Net Income towards Common Stockholders was -$75.8 million.
- Going back by year, Net Income towards Common Stockholders was -$71.27 million in FY2024, -$64.47 million in FY2023, -$37.69 million in FY2022 and -$30.64 million in FY2021.
- The Q4 2025 figure represents the highest quarterly Net Income towards Common Stockholders since Q1 2022.
- Business Quant data shows JSPR's Net Income towards Common Stockholders at -$18.74 million (Q3 2025), -$26.72 million (Q2 2025) and -$21.24 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.26 Bn | 1,100.85 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 634.57 Bn | 554.43 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 505.88 Bn | 478.99 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 291.59 Bn | 255.58 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 265.00 Bn | 238.69 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 238.10 Bn | 193.50 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 195.13 Bn | 169.32 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 171.11 Bn | 117.76 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Jasper Therapeutics | 15.26 Mn | -111.15 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -9.10 Mn |
| Sep 30, 2025 | -18.74 Mn |
| Jun 30, 2025 | -26.72 Mn |
| Mar 31, 2025 | -21.24 Mn |
| Dec 31, 2024 | -24.35 Mn |
| Sep 30, 2024 | -18.64 Mn |
| Jun 30, 2024 | -14.58 Mn |
| Mar 31, 2024 | -13.73 Mn |
| Dec 31, 2023 | -16.62 Mn |
| Sep 30, 2023 | -17.54 Mn |
| Jun 30, 2023 | -16.08 Mn |
| Mar 31, 2023 | -14.26 Mn |
| Dec 31, 2022 | -16.11 Mn |
| Sep 30, 2022 | -11.86 Mn |
| Jun 30, 2022 | -10.40 Mn |
| Mar 31, 2022 | -2.21 Mn |
| Dec 31, 2021 | -6.16 Mn |
| Sep 30, 2021 | -3.41 Mn |
| Jun 30, 2021 | -3.41 Mn |
| Mar 31, 2021 | -9.75 Mn |
API Access
Jasper Therapeutics Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=JSPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "JSPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=JSPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();